Urine YKL-40 is associated with progressive acute kidney injury or death in hospitalized patients

被引:0
作者
Isaac E Hall
Edward P Stern
Lloyd G Cantley
Jack A Elias
Chirag R Parikh
机构
[1] Yale School of Medicine,Section of Nephrology, Department of Internal Medicine
[2] Yale School of Medicine,Program of Applied Translational Research
[3] University College London/Royal Free London NHS Foundation Trust,Centre for Nephrology
[4] Brown University,Division of Biology and Medicine
来源
BMC Nephrology | / 15卷
关键词
Acute kidney injury; Biomarker; BRP-39; Chitinase 3-like-1; Net reclassification improvement; YKL-40;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 187 条
  • [11] Prakash J(2010)IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation J Am Soc Nephrol 21 189-197
  • [12] Susantitaphong P(2013)Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications Acta Physiol (Oxf) 207 663-672
  • [13] Cruz DN(2013)Chitinase-Like Protein Brp-39/YKL-40 Modulates the Renal Response to Ischemic Injury and Predicts Delayed Allograft Function J Am Soc Nephrol 24 309-319
  • [14] Cerda J(2001)Phases of biomarker development for early detection of cancer J Natl Cancer Inst 93 1054-1061
  • [15] Abulfaraj M(2007)Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury Crit Care 11 R31-254
  • [16] Alqahtani F(2006)Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 247-312
  • [17] Koulouridis I(2012)Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients J Diabetes Complications 26 308-1802
  • [18] Jaber BL(2013)Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue? Clin Chem Lab Med 51 1795-21
  • [19] Chertow GM(2011)Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 11-481
  • [20] Burdick E(2012)Interpreting incremental value of markers added to risk prediction models Am J Epidemiol 176 473-501